JAZZ Band
-
Spine
Implanet Presents Independent Radiological Results of the JAZZ Band at the SRS 52nd Annual Meeting & Course
September 05, 2017 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible) (Paris:IMPL) (OTCQX:IMPZY), a medical…
Read More » -
Recon
IMPLANET announces the 10,000th JAZZ Band sold
Bordeaux, Boston, 13 October 2015 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and…
Read More » -
Recon
Implanet enrolls first patient in a major multi-center clinical study led by the Ohio State University
Bordeaux, Boston, June 16, 2015 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today…
Read More » -
Hospitals
IMPLANET: CE Mark and FDA Clearance in the United States for New JAZZ Diameters
IMPLANET (Paris: IMPL) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, today announces that…
Read More » -
Extremities
Implanet Announces Publication of a Cost Effectiveness Study of JAZZ™ Band in Adolescent Idiopathic Scoliosis
BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specialized in vertebral and…
Read More »